116 related articles for article (PubMed ID: 37096786)
1. The "Medicare effect" on head and neck cancer diagnosis and survival.
Smith JB; Jayanth P; Hong SA; Simpson MC; Massa ST
Head Neck; 2023 Jul; 45(7):1663-1675. PubMed ID: 37096786
[TBL] [Abstract][Full Text] [Related]
2. Association of the Patient Protection and Affordable Care Act With Insurance Coverage for Head and Neck Cancer in the SEER Database.
Cannon RB; Shepherd HM; McCrary H; Carpenter PS; Buchmann LO; Hunt JP; Houlton JJ; Monroe MM
JAMA Otolaryngol Head Neck Surg; 2018 Nov; 144(11):1052-1057. PubMed ID: 30242321
[TBL] [Abstract][Full Text] [Related]
3. Patterns of Multidisciplinary Care of Head and Neck Squamous Cell Carcinoma in Medicare Patients.
Hansen CC; Egleston B; Leachman BK; Churilla TM; DeMora L; Ebersole B; Bauman JR; Liu JC; Ridge JA; Galloway TJ
JAMA Otolaryngol Head Neck Surg; 2020 Dec; 146(12):1136-1146. PubMed ID: 33090191
[TBL] [Abstract][Full Text] [Related]
4. Influence of Medicaid Expansion on Head and Neck Squamous Cell Carcinoma Presentation and Survival.
Arch RS; Fei-Zhang DJ; Patel U; Rastatter JC
Otolaryngol Head Neck Surg; 2024 Feb; 170(2):431-437. PubMed ID: 37811691
[TBL] [Abstract][Full Text] [Related]
5. Association of Medicaid Expansion Under the Affordable Care Act With Stage at Diagnosis and Time to Treatment Initiation for Patients With Head and Neck Squamous Cell Carcinoma.
Sineshaw HM; Ellis MA; Yabroff KR; Han X; Jemal A; Day TA; Graboyes EM
JAMA Otolaryngol Head Neck Surg; 2020 Mar; 146(3):247-255. PubMed ID: 31944232
[TBL] [Abstract][Full Text] [Related]
6. Insurance status, stage of presentation, and survival among female patients with head and neck cancer.
Panth N; Simpson MC; Sethi RKV; Varvares MA; Osazuwa-Peters N
Laryngoscope; 2020 Feb; 130(2):385-391. PubMed ID: 30900256
[TBL] [Abstract][Full Text] [Related]
7. The impact of health insurance status on the survival of patients with head and neck cancer.
Kwok J; Langevin SM; Argiris A; Grandis JR; Gooding WE; Taioli E
Cancer; 2010 Jan; 116(2):476-85. PubMed ID: 19937673
[TBL] [Abstract][Full Text] [Related]
8. Health-related quality of life before and after head and neck squamous cell carcinoma: Analysis of the Surveillance, Epidemiology, and End Results-Medicare Health Outcomes Survey linkage.
Rettig EM; D'Souza G; Thompson CB; Koch WM; Eisele DW; Fakhry C
Cancer; 2016 Jun; 122(12):1861-70. PubMed ID: 27182694
[TBL] [Abstract][Full Text] [Related]
9. Health Insurance Affects Head and Neck Cancer Treatment Patterns and Outcomes.
Inverso G; Mahal BA; Aizer AA; Donoff RB; Chuang SK
J Oral Maxillofac Surg; 2016 Jun; 74(6):1241-7. PubMed ID: 26851312
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of Comorbidities among Older Head and Neck Cancer Survivors in the United States.
Eytan DF; Blackford AL; Eisele DW; Fakhry C
Otolaryngol Head Neck Surg; 2019 Jan; 160(1):85-92. PubMed ID: 30252608
[TBL] [Abstract][Full Text] [Related]
11. Hospital volume is associated with survival but not multimodality therapy in Medicare patients with advanced head and neck cancer.
Sharma A; Schwartz SM; Méndez E
Cancer; 2013 May; 119(10):1845-52. PubMed ID: 23456789
[TBL] [Abstract][Full Text] [Related]
12. Patterns of care in older patients with squamous cell carcinoma of the head and neck: a surveillance, epidemiology, and end results-medicare analysis.
VanderWalde NA; Meyer AM; Liu H; Tyree SD; Zullig LL; Carpenter WR; Shores CD; Weissler MC; Hayes DN; Fleming M; Chera BS
J Geriatr Oncol; 2013 Jul; 4(3):262-70. PubMed ID: 24058388
[TBL] [Abstract][Full Text] [Related]
13. Adherence to Guideline-Concordant Care and Its Effect on Survival in Black Patients with Head and Neck Cancers: A SEER-Medicare Analysis.
Vyfhuis MAL; Suzuki I; Bentzen SM; Cullen KJ; Goloubeva OG
Oncologist; 2021 Jul; 26(7):579-587. PubMed ID: 33783061
[TBL] [Abstract][Full Text] [Related]
14. Survival outcomes for head and neck patients with Medicaid: A health insurance paradox.
Pannu JS; Simpson MC; Adjei Boakye E; Massa ST; Cass LM; Challapalli SD; Rohde RL; Osazuwa-Peters N
Head Neck; 2021 Jul; 43(7):2136-2147. PubMed ID: 33780066
[TBL] [Abstract][Full Text] [Related]
15. Survival of patients with head and neck cancer treated with definitive radiotherapy and concurrent cisplatin or concurrent cetuximab: A Surveillance, Epidemiology, and End Results-Medicare analysis.
Xiang M; Holsinger FC; Colevas AD; Chen MM; Le QT; Beadle BM
Cancer; 2018 Dec; 124(23):4486-4494. PubMed ID: 30332498
[TBL] [Abstract][Full Text] [Related]
16. Role of physician density in predicting stage and survival for head and neck squamous cell carcinoma.
Gadkaree SK; McCarty JC; Feng AL; Siu JM; Burks CA; Deschler DG; Richmon JD; Varvares MA; Bergmark RW
Head Neck; 2021 Feb; 43(2):438-448. PubMed ID: 33015935
[TBL] [Abstract][Full Text] [Related]
17. Impact of insurance on survival in patients < 65 with head & neck cancer treated with radiotherapy.
Sittig MP; Luu M; Yoshida EJ; Scher K; Mita A; Shiao SL; Lu DJ; Mallen-St Clair J; Ho AS; Zumsteg ZS
Clin Otolaryngol; 2020 Jan; 45(1):63-72. PubMed ID: 31661188
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of comorbidities and effect on survival in survivors of human papillomavirus-related and human papillomavirus-unrelated head and neck cancer in the United States.
Eytan DF; Blackford AL; Eisele DW; Fakhry C
Cancer; 2019 Jan; 125(2):249-260. PubMed ID: 30444527
[TBL] [Abstract][Full Text] [Related]
19. The Impact of Medicaid Expansion on Head and Neck Malignancies Presentation and Survival.
Al-Qurayshi Z; Sullivan CB; Shama MA; Pagedar NA; Kandil E
Laryngoscope; 2023 Jun; 133(6):1409-1414. PubMed ID: 37158264
[TBL] [Abstract][Full Text] [Related]
20. Insurance status as a predictor of mortality in patients undergoing head and neck cancer surgery.
Rohlfing ML; Mays AC; Isom S; Waltonen JD
Laryngoscope; 2017 Dec; 127(12):2784-2789. PubMed ID: 28639701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
